Acute Leukemia of Ambiguous Lineage - 35 Studies Found Completed : Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation : Leukemia Lymphoma Allogeneic Haematopoietic Stem Cell Tran : 2009-10-02 : Drug: Busulfan Test Dose 32 mg Not yet recruiting : Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic Malignancies : Hematologic Malignancy : 2016-03-16 : Drug: Fludarabine Recruiting : Cladribine Plus Idarubicin Plus Cytarabine (ARAC) in Patients With Acute Myeloid Leukemia (AML), High Risk Myelodysplastic Syndrome (HR MDS) or Myeloid Blast Phase of Chronic Myeloid Leukemia (CML) : Leukemia : 2014-04-14 : Drug: Cladribine RECRUITING : Venetoclax Combined With Azactidine in the Treatment of ALAL : : 2024-05-20 : Venetoclax orally once daily (100 mg d1, 200 mg d2, 400 mg d3-28); RECRUITING : A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia : Recurrent Acute Leukemia of Ambiguous Lineage : 2024-05-20 : Undergo collection of blood and bone marrow samples <<< Previous